AUA (PC) 21-May-08
From Kidney Cancer Resource
To Go To AUA (PC)
American Urological Association (AUA) Clinical Guidelines Recognizes Cryotherapy as Treatment Option for Prostate Cancer Patients
YOKNEAM, Israel and PLYMOUTH MEETING, Pennsylvania, May 21 /PRNewswire/ --
The New Best Practice Statements Were Presented at the AUA Annual Meeting Being Held in Orlando, Florida
Galil Medical, a global leader in cryotherapy, announced today that the American Urological Association has introduced clinical guidelines with best practice statements for prostate cryotherapy. The guidelines state that cryoablation is a treatment option for men with clinically confined prostate cancer of any grade and that salvage cryoablation is a treatment option in men who have failed radiation therapy.
Prostate cryotherapy uses extreme cold to freeze and destroy prostate cancer cells. This minimally invasive procedure is routinely and successfully performed on prostate cancer patients with varying disease stages as well as those who have failed radiation treatment. Prostate cancer is the most common cancer, other than skin cancers, in American men. The American Cancer Society estimates that during 2008 about 186,320 new cases of prostate cancer will be diagnosed in the United States.
The American Urological Association (AUA), the premier professional association for the advancement of urologic patient care, routinely adopts clinical guidelines and best practice statements, releasing updates as technology improves. Dr. Richard Babaian, Professor and Senior Medical Director at the MD Anderson Physician Network, presented the new guidelines for cryotherapy for the treatment of localized prostate cancer at the plenary session of the AUA annual meeting.
Martin J. Emerson, Galil Medical President and CEO comments, "We are pleased that the AUA, in its preeminent role in assessing new treatment options for urologists and their patients, now recognizes cryotherapy as a mainstream treatment option for patients diagnosed with localized prostate cancer."
Urologists can learn first-hand about cryotherapy at the Cryosurgical Ablation of the Prostate course being presented during the AUA annual meeting on Thursday, May 22, 2008 from 6-8 a.m.
A recently published retrospective study of primary prostate cryotherapy by Dr. Jeffrey Cohen reported 10-year follow up data with biochemical control comparable to external beam radiotherapy or prostate brachytherapy. The literature has also shown that advances over the last 10 years in cryoablation techniques have dramatically improved the morbidity profile.
New guidelines for the treatment of localized prostate cancer were released by the AUA in 2007 and emphasized communication with the patient regarding risk, treatment options, and potential outcomes. At that time, it was recognized that cryotherapy for the treatment of localized prostate cancer should be the topic of an AUA best practice policy.
About Galil Medical
To view the original of this article Click Here
Disclaimer
Kidney Cancer Resource (KCR) is not influenced by sponsors. The information contained herein is not intended as a substitute for the advice of an appropriately qualified and licensed physician or other licensed health care provider. The information provided here is for educational and information purposes only. Early accurate Diagnosis (Dx.) saves lives. Please check with a physician if you suspect you are ill, never ignore Symptoms. To help your health care specialist make an accurate Diagnosis please keep notes of dates, times and details of your Symptoms. We are not offering medical advice nor do we consider links, individuals or articles accessed through this site to be offering medical advice.
E&OE - Errors & Omissions Excepted
As much of the information posted on this Web Site for peoples convenience is of a medical or technical nature, and may be a matter of life or death the E&OE is a Disclaimer showing that to the best of our ability information is accurate and correctly written or transcribed. Before acting on information on this site you are responsible for checking it with your relevant medical team. We can not be held responsible for any Errors & Omissions made; nor for information on links and articles provided in good faith.
